DL-Tyrosine

Name: <SC>DL</SC>-Tyrosine
Brand: ALDRICH

99%

Synonym(s):

(±)-2-Amino-3-(4-hydroxyphenyl)propionic acid, 3-(4-Hydroxyphenyl)-DL-alanine

Slide 1 of 3

Select a Size

Pricing and availability is not currently available.

About This Item

Linear Formula:

4-(HO)C₆H₄CH₂CH(NH₂)COOH

CAS Number:

556-03-6

Molecular Weight:

181.19

UNSPSC Code:

12352209

NACRES:

NA.22

PubChem Substance ID:

24848742

EC Number:

209-113-1

Beilstein/REAXYS Number:

515881

MDL number:

MFCD00063074

Key Documents

View All Documentation

Product Name

DL-Tyrosine, 99%

InChI key

OUYCCCASQSFEME-UHFFFAOYSA-N

InChI

1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)

SMILES string

NC(Cc1ccc(O)cc1)C(O)=O

assay

99%

form

powder

reaction suitability

reaction type: solution phase peptide synthesis

mp

≥300 °C (lit.)

application(s)

peptide synthesis

Quality Level

100

Looking for similar products? Visit Product Comparison Guide

Related Categories

Building Blocks, Resins, and Coupling Reagents for GLP-1 Synthesis

Amino Acids, Resins & Reagents for Peptide Synthesis

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item	855456	T3754	T2006
Sigma-Aldrich 145726 DL-Tyrosine	Sigma-Aldrich 855456 D-Tyrosine	Sigma-Aldrich T3754 L-Tyrosine	Sigma-Aldrich T2006 L-Tyrosine hydrochloride
form powder	form powder	form powder	form powder
assay 99%	assay 99%	assay ≥98% (HPLC)	assay ≥98% (TLC)
mp ≥300 °C (lit.)	mp >300 °C (lit.)	mp >300 °C (dec.) (lit.)	mp 239 °C (dec.) (lit.)
Quality Level 100	Quality Level 100	Quality Level 200	Quality Level 200
reaction suitability reaction type: solution phase peptide synthesis	reaction suitability reaction type: solution phase peptide synthesis	reaction suitability -	reaction suitability -
application(s) peptide synthesis	application(s) peptide synthesis	application(s) detection	application(s) -

Storage Class

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.

W D Phillips et al.

Experimental neurology, 270, 29-40 (2014-12-30)

Muscle-specific tyrosine kinase (MuSK) autoantibodies are the hallmark of a form of myasthenia gravis (MG) that can challenge the neurologist and the experimentalist. The clinical disease can be difficult to treat effectively. MuSK autoantibodies affect the neuromuscular junction in several

Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.

Shannon L Maude et al.

Blood, 125(11), 1759-1767 (2015-02-04)

Early T-cell precursor (ETP) acute lymphoblastic leukemia (ALL) is a recently described subtype of T-ALL characterized by a unique immunophenotype and genomic profile, as well as a high rate of induction failure. Frequent mutations in cytokine receptor and Janus kinase

Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.

Martin Schlumberger et al.

The New England journal of medicine, 372(7), 621-630 (2015-02-12)

Lenvatinib, an oral inhibitor of vascular endothelial growth factor receptors 1, 2, and 3, fibroblast growth factor receptors 1 through 4, platelet-derived growth factor receptor α, RET, and KIT, showed clinical activity in a phase 2 study involving patients with

Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience.

Philippe Menasché et al.

European heart journal, 36(12), 743-750 (2014-05-20)

There is now compelling evidence that cells committed to a cardiac lineage are most effective for improving the function of infarcted hearts. This has been confirmed by our pre-clinical studies entailing transplantation of human embryonic stem cell (hESC)-derived cardiac progenitors

Converging circuits mediate temperature and shock aversive olfactory conditioning in Drosophila.

Dana Shani Galili et al.

Current biology : CB, 24(15), 1712-1722 (2014-07-22)

Drosophila learn to avoid odors that are paired with aversive stimuli. Electric shock is a potent aversive stimulus that acts via dopamine neurons to elicit avoidance of the associated odor. While dopamine signaling has been demonstrated to mediate olfactory electric

View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service